BMS 754807

BMS 754807

CAT N°: 17505
Price:

From 66.00 56.10

BMS 754807 is a reversible, orally bioavailable dual inhibitor of insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (InsR) tyrosine kinases (IC50s = 1.8 and 1.7 nM, respectively).{28722,28719} It has minimal effect against an array of other tyrosine and serine/threonine kinases.{28722} BMS 754807 inhibits cell proliferation or induces apoptosis in a variety of cancer cells in vitro.{28719} It inhibits the growth of tumor xenografts in mice and this effect is often enhanced by combination therapy with other chemotherapeutics.{28719,28718,28720} Predictive biomarkers, including elevated IGF-1R expression, for effectiveness of BMS 754807 have been delineated.{28721}

We also advise you